The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 81.
77. lappuse
... composition of matter is not new , it still cannot be patented . The decision of the Court of Customs and Patent Appeals in In re Thuau , 50 has not been overruled by the statute . The hold- ing of this decision is simply that an old ...
... composition of matter is not new , it still cannot be patented . The decision of the Court of Customs and Patent Appeals in In re Thuau , 50 has not been overruled by the statute . The hold- ing of this decision is simply that an old ...
241. lappuse
... composition claims recited " A pesticidal composition comprising a surface active agent as a relatively inert pesticidal adjuvant and as an active ingred- ient ( naming the compounds ) . " It was contended that such claims were ...
... composition claims recited " A pesticidal composition comprising a surface active agent as a relatively inert pesticidal adjuvant and as an active ingred- ient ( naming the compounds ) . " It was contended that such claims were ...
242. lappuse
... composition cases will go off on a fortuitous cir- cumstance somewhat analogous to the Thuau doctrine . The Thuau doctrine holds that where a compound is in the art ( or , indeed , a composition ) , no claims can be obtained to it ...
... composition cases will go off on a fortuitous cir- cumstance somewhat analogous to the Thuau doctrine . The Thuau doctrine holds that where a compound is in the art ( or , indeed , a composition ) , no claims can be obtained to it ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention